Page last updated: 2024-08-18

pyrroles and Chlamydia pneumoniae Infections

pyrroles has been researched along with Chlamydia pneumoniae Infections in 3 studies

Research

Studies (3)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	2 (66.67)	29.6817
2010's	1 (33.33)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Thibault, PK	1
Dechend, R; Dietz, R; Gieffers, J; Joerres, A; Luft, FC; Maass, M; Rupp, J	1
Belder, R; Braunwald, E; Breen, J; Cannon, CP; McCabe, CH	1

Reviews

1 review(s) available for pyrroles and Chlamydia pneumoniae Infections

Article	Year
Neck vein obstruction: Diagnosis and the role of chronic persistent Phlebology, 2019, Volume: 34, Issue:6 Topics: Chlamydophila Infections; Chlamydophila pneumoniae; Chronic Disease; Humans; Neck; Pyrimidines; Pyrroles; Vascular Diseases	2019

Other Studies

2 other study(ies) available for pyrroles and Chlamydia pneumoniae Infections

Article	Year
Hydroxymethylglutaryl coenzyme A reductase inhibition reduces Chlamydia pneumoniae-induced cell interaction and activation. Circulation, 2003, Jul-22, Volume: 108, Issue:3 Topics: Animals; Arteriosclerosis; Atorvastatin; Cell Communication; Cell Membrane; Cells, Cultured; Chemokines; Chlamydophila Infections; Chlamydophila pneumoniae; Coculture Techniques; Dose-Response Relationship, Drug; Enzyme Activation; Heptanoic Acids; Humans; Hydroxymethylglutaryl CoA Reductases; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Macrophages; Mice; Mice, Knockout; Muscle, Smooth, Vascular; NF-kappa B; Protein Prenylation; Pyridines; Pyrroles; rac1 GTP-Binding Protein; Reactive Oxygen Species; rhoA GTP-Binding Protein; RNA, Messenger; Signal Transduction	2003
Design of the Pravastatin or Atorvastatin Evaluation and Infection Therapy (PROVE IT)-TIMI 22 trial. The American journal of cardiology, 2002, Apr-01, Volume: 89, Issue:7 Topics: Angina, Unstable; Anti-Infective Agents; Anticholesteremic Agents; Atorvastatin; Chlamydophila Infections; Chlamydophila pneumoniae; Cholesterol, LDL; Double-Blind Method; Fluoroquinolones; Gatifloxacin; Heptanoic Acids; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Multicenter Studies as Topic; Myocardial Infarction; Pneumonia, Bacterial; Pravastatin; Pyrroles; Randomized Controlled Trials as Topic; Research Design	2002

Article

Year

Hydroxymethylglutaryl coenzyme A reductase inhibition reduces Chlamydia pneumoniae-induced cell interaction and activation.

Circulation, 2003, Jul-22, Volume: 108, Issue:3

Topics: Animals; Arteriosclerosis; Atorvastatin; Cell Communication; Cell Membrane; Cells, Cultured; Chemokines; Chlamydophila Infections; Chlamydophila pneumoniae; Coculture Techniques; Dose-Response Relationship, Drug; Enzyme Activation; Heptanoic Acids; Humans; Hydroxymethylglutaryl CoA Reductases; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Macrophages; Mice; Mice, Knockout; Muscle, Smooth, Vascular; NF-kappa B; Protein Prenylation; Pyridines; Pyrroles; rac1 GTP-Binding Protein; Reactive Oxygen Species; rhoA GTP-Binding Protein; RNA, Messenger; Signal Transduction

2003

Design of the Pravastatin or Atorvastatin Evaluation and Infection Therapy (PROVE IT)-TIMI 22 trial.

The American journal of cardiology, 2002, Apr-01, Volume: 89, Issue:7

Topics: Angina, Unstable; Anti-Infective Agents; Anticholesteremic Agents; Atorvastatin; Chlamydophila Infections; Chlamydophila pneumoniae; Cholesterol, LDL; Double-Blind Method; Fluoroquinolones; Gatifloxacin; Heptanoic Acids; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Multicenter Studies as Topic; Myocardial Infarction; Pneumonia, Bacterial; Pravastatin; Pyrroles; Randomized Controlled Trials as Topic; Research Design

2002